Maria Edebrink
General Counsel bei XBRANE BIOPHARMA AB
Vermögen: 4 641 $ am 30.04.2024
Profil
Maria Edebrink currently works at Xbrane Biopharma AB, as Head-Regulatory Affairs & Quality Assurance from 2021.
Ms. Edebrink also formerly worked at Medivir AB, as Head-Regulatory Affairs and AstraZeneca AB, as Head-Regulatory Affairs.
Ms. Edebrink received her graduate degree from the University of Stockholm.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
XBRANE BIOPHARMA AB
0,02% | 05.09.2023 | 235 210 ( 0,02% ) | 4 641 $ | 30.04.2024 |
Aktive Positionen von Maria Edebrink
| Unternehmen | Position | Beginn |
|---|---|---|
| XBRANE BIOPHARMA AB | General Counsel | 01.01.2019 |
Ehemalige bekannte Positionen von Maria Edebrink
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIVIR AB | General Counsel | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | General Counsel | - |
Ausbildung von Maria Edebrink
| University of Stockholm | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| XBRANE BIOPHARMA AB | Health Technology |
| MEDIVIR AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
